Edwards Lifesciences Corp — Director's Dealing 2021

Jun 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-06-14

Reporting Person: Wood Larry L (CVP, TAVR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	M	7830.0000	$35.1967	Acquired	379901.5231	Direct
2021-06-14	Common Stock	S	7830.0000	$99.9100	Disposed	372071.5231	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Employee Stock Option (Right to Acquire)	$35.1967	M	7830.0000	Disposed	2023-05-11	Common Stock (7830.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	495.9158	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

F2: Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.